85.52
Overview
News
Price History
Option Chain
Financials
Why MET Down?
Discussions
Forecast
Dividend History
Metlife Inc stock is traded at $85.52, with a volume of 1.16M.
It is down -2.79% in the last 24 hours and up +1.80% over the past month.
MetLife is one of the largest life insurers in the US by assets and provides a variety of life insurance and annuity products. It is organized into six segments: Group Benefits, Retirement and Income Solutions, Asia, Latin America, Europe/Middle East/Africa (EMEA), and MetLife Holdings (products in run-off). Group Benefits and RIS are US-based, contributing to around 48% of the firm's 2024 adjusted earnings. The Asia segment contributes around 25% of earnings, mainly tied to Japan. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 13% of 2024 earnings. The EMEA and MetLife Holdings segments contributed around 4% and 10% of 2024 earnings, respectively.
See More
Previous Close:
$88.03
Open:
$88.03
24h Volume:
1.16M
Relative Volume:
0.33
Market Cap:
$55.02B
Revenue:
$77.59B
Net Income/Loss:
$3.62B
P/E Ratio:
16.54
EPS:
5.1701
Net Cash Flow:
$16.53B
1W Performance:
-0.33%
1M Performance:
+1.80%
6M Performance:
+5.58%
1Y Performance:
+7.42%
Metlife Inc Stock (MET) Company Profile
Name
Metlife Inc
Sector
Industry
Phone
212-578-5500
Address
200 PARK AVENUE, NEW YORK, NY
Compare MET vs MFC, AFL, PRU, PUK
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
MET
Metlife Inc
|
85.51 | 56.64B | 77.59B | 3.62B | 16.53B | 5.1701 |
|
MFC
Manulife Financial Corp
|
39.80 | 66.94B | 44.31B | 4.69B | 20.94B | 2.5185 |
|
AFL
Aflac Inc
|
117.85 | 60.46B | 18.11B | 4.64B | 2.93B | 8.812 |
|
PRU
Prudential Financial Inc
|
106.77 | 37.68B | 62.83B | 3.60B | 9.79B | 9.7297 |
|
PUK
Prudential Plc Adr
|
26.31 | 33.35B | 27.81B | 4.12B | 1.87B | 3.07 |
Metlife Inc Stock (MET) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-06-26 | Downgrade | Evercore ISI | Outperform → In-line |
| Dec-16-25 | Initiated | Mizuho | Outperform |
| Sep-19-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-16-25 | Initiated | Wolfe Research | Outperform |
| Jan-23-25 | Initiated | BMO Capital Markets | Market Perform |
| Oct-09-24 | Initiated | TD Cowen | Buy |
| Sep-05-24 | Initiated | Barclays | Overweight |
| Jan-08-24 | Upgrade | Goldman | Neutral → Buy |
| Nov-17-23 | Resumed | Barclays | Overweight |
| Oct-05-23 | Initiated | Deutsche Bank | Hold |
| Sep-14-23 | Upgrade | Jefferies | Hold → Buy |
| Jan-09-23 | Downgrade | Goldman | Buy → Neutral |
| Dec-09-22 | Downgrade | Jefferies | Buy → Hold |
| Sep-22-22 | Initiated | Raymond James | Mkt Perform |
| Jun-23-22 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| May-24-22 | Initiated | Citigroup | Buy |
| Jan-26-22 | Initiated | Jefferies | Buy |
| Jan-21-22 | Initiated | Wolfe Research | Peer Perform |
| Jan-12-22 | Reiterated | UBS | Buy |
| Jan-05-22 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-03-21 | Initiated | Goldman | Buy |
| Apr-21-21 | Initiated | UBS | Buy |
| Jan-06-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-08-20 | Upgrade | Citigroup | Neutral → Buy |
| Dec-04-20 | Initiated | Goldman | Neutral |
| Nov-17-20 | Initiated | Barclays | Overweight |
| Jun-01-20 | Resumed | BofA/Merrill | Buy |
| Mar-16-20 | Upgrade | Citigroup | Sell → Neutral |
| Jan-07-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jul-16-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Mar-19-19 | Downgrade | Sandler O'Neill | Buy → Hold |
| Jan-16-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jan-02-19 | Upgrade | Sandler O'Neill | Hold → Buy |
| Jun-04-18 | Downgrade | Goldman | Buy → Neutral |
| Apr-25-18 | Initiated | Credit Suisse | Outperform |
| Mar-26-18 | Upgrade | Atlantic Equities | Neutral → Overweight |
| Jan-02-18 | Initiated | Deutsche Bank | Hold |
| Nov-10-17 | Downgrade | Sandler O'Neill | Buy → Hold |
| Nov-03-17 | Reiterated | RBC Capital Mkts | Outperform |
| May-25-17 | Upgrade | FBR & Co. | Mkt Perform → Outperform |
| Mar-06-17 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jan-26-17 | Initiated | Citigroup | Sell |
| Dec-09-16 | Downgrade | Standpoint Research | Buy → Hold |
View All
Metlife Inc Stock (MET) Latest News
New MetLife Study Reveals a 72% “Confidence Gap” in Ability to Recover from Life's Setbacks - Business Wire
Investor who scored in 2008 crisis bets against insurersreport (MET:NYSE) - Seeking Alpha
PNB MetLife settles 99.81% of individual claims in FY26, pays out over ₹1,029 crore - BusinessLine
MetLife outlines 2026 governance roadmap, shares tracked against S&P 500 insurers - Ad-hoc-news.de
MetLife Bangladesh settles highest claims among peers in Q1 - daily-sun.com
MetLife holds 2026 shareholder meeting, governance decisions frame the stock - Ad-hoc-news.de
MetLife, Inc. (MET) Announces Results of Annual Shareholder Meeting - GuruFocus
Can MetLife (NYSE:MET) Flexible Products Strengthen S&P 500 Position? - Kalkine Media
MetLife, Inc. 8-K Filing: Key Company Information, Stock Details, and SEC Compliance (June 2026) - Minichart
MetLife shareholders elect directors and approve proposals at annual meeting - Investing.com Canada
MetLife Inc. stock outperforms competitors on strong trading day - MarketWatch
Form 8K Metlife For: 22 June By Investing.com - Investing.com Canada
Metlife requests receiver on Rockpoint’s Miracle Mile office tower, alleging default - The Real Deal
MetLife Pet Insurance Expands Grief Support for Pet Parents with Memorial Tree Program - InsuranceNewsNet
MetLife outlines capital priorities ahead of next earnings, shares in S&P 500 insurance spotlight - AD HOC NEWS
ZAWYA: MetLife and ALEXBANK celebrate their renewed strategic partnership to strengthen bancassurance services - TradingView
Why MetLife’s Pet Insurance could matter more than you think - AD HOC NEWS
MetLife StockWeekly review against US insurers - AD HOC NEWS
MetLife Inc (MET) Valuation: PE, PB & Fair Value Analysis - TradingKey
MetLife Inc (MET) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
MetLife Korea Creates 100-Pyeong 'School Forest' at Seoul's Ssangmun Elementary - Seoul Economic Daily
MetLife Inc (MET) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
MetLife Inc (MET) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
MetLife Inc (MET) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
MetLife Inc (MET) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
MetLife Inc (MET) Institutional Confidence - TradingKey
MetLife Inc (MET) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
MetLife Inc. stock outperforms competitors despite losses on the day - MarketWatch
Ex-Sidley Austin Partner Sues MetLife Over Disability Benefits - Bloomberg Law News
MetLife (MET) Stock And The Valuation Puzzle After Strong Multi‑Year Gains - Yahoo Finance
Recurring premiums, MetLife Pet Insurance targets budget-conscious owners - AD HOC NEWS
MetLife Inc. Stock (US59156R1086): Near Record High As Valuation Premium Widens - AD HOC NEWS
MetLife Expands Settlement Offerings With New Flex Agreement And Valuation Upside - Yahoo Finance
ZAWYA: Orange Jordan & MetLife partner to offer insurance services via Orange Money - TradingView
MetLife (MET) Q4 2025 earnings summary - Quartr
MetLife Appoints Najla Frayha as Chief Marketing Officer, U.S. Group Benefits - hrtoday.in
Is MetLife stock outperforming the S&P 500? - MSN
MetLife’s New Flexible Settlement Tool Could Reshape Its Structured Solutions Story - Sahm
MetLife Stadium? Lumen Field? Not during the World Cup - Fast Company
MetLife on Track for Record High Close -- Data Talk - Moomoo
Metlife Preferreds Update: Series A Drops From Hold To Sell; Others Stay Holds (MET.PR.A) - Seeking Alpha
MetLife broadens settlement solutions portfolio with NQA-FA - MSN
MetLife Inc. stock rises Thursday, still underperforms market - MarketWatch
MetLife (MET) director McKenzie credited 169 shares via deferred dividend reinvestment - Stock Titan
[Form 4] METLIFE INC Insider Trading Activity - Stock Titan
MetLife (NYSE: MET) director adds 39 deferred shares via dividends - Stock Titan
MetLife (MET) director Jeh C. Johnson acquires 61 shares through deferred dividend reinvestment - Stock Titan
MetLife (MET) director granted 42 shares via dividend reinvestment - Stock Titan
MetLife (MET) director adds 20 shares via deferred dividend reinvestment - Stock Titan
MetLife (NYSE: MET) director gains 7 shares via deferred compensation plan - Stock Titan
MetLife (NYSE: MET) director gains 678 shares via deferred stock plan - Stock Titan
Metlife Inc Stock (MET) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):